Grabar Law Office has filed a class action lawsuit on behalf of independent pharmacies, challenging the anticompetitive practices of GoodRx Holdings, Inc. and four major pharmacy benefit managers (PBMs): CVS Caremark, Express Scripts, MedImpact, and Navitus Health Solutions. The complaint alleges that these PBMs conspired to use GoodRx’s discount card system to artificially lower reimbursement rates paid to pharmacies while collecting excessive fees, harming both independent pharmacies and consumers.
Allegations of Price Fixing and Market Manipulation
The lawsuit contends that the defendants engaged in a price-fixing scheme, leveraging GoodRx as a clearinghouse to share real-time pricing data and reroute prescription transactions. This arrangement maximized profits for the PBMs and GoodRx but led to significant financial losses for independent pharmacies, which rely on fair reimbursements to remain operational. The case further highlights how these practices have accelerated the closure of independent pharmacies, limiting consumer choice and driving up healthcare costs.
Why It Matters
The actions of GoodRx and the PBM defendants are said to have undermined competition in the prescription drug market, placing additional financial strain on community pharmacies and threatening patient access to vital healthcare services. By joining this class action, pharmacies can seek compensation for underpaid reimbursements, seek injunctive relief, and stand against unfair practices that disrupt the industry.
To learn more about this case or to see if your pharmacy qualifies to join, contact Joshua Grabar directly at [email protected] or call 267-507-6085.
